U.S. market Closed. Opens in 23 hours 57 minutes

ZYXI | Zynex, Inc. Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 8.21 - 8.72
52 Week Range 7.15 - 13.77
Beta 0.44
Implied Volatility 79.66%
IV Rank 58.46%
Day's Volume 321,297
Average Volume 86,312
Shares Outstanding 31,845,500
Market Cap 262,725,375
Sector Healthcare
Industry Medical - Distribution
IPO Date 2004-02-25
Valuation
Profitability
Growth
Health
P/E Ratio 58.93
Forward P/E Ratio 32.09
EPS 0.14
1YR Price Target 16.75
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 1,100
Country USA
Website ZYXI
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufacture, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. it also develops and markets medical devices for non-invasive cardiac monitoring, the products of which are under development. The company markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave and others.
ZYXI's peers: AHG, CAH, EDAP, HSIC, MCK, OMI, RDUS, ABC, PDCO
*Chart delayed
Analyzing fundamentals for ZYXI we got that it has average fundamentals where Valuation is considered to be slightly overvalued, Profitability is poor, Growth is exceptionally good and Health is strong. For more detailed analysis please see ZYXI Fundamentals page.

Watching at ZYXI technicals we can see that long-term trend is bearish, while middle-term trend is bullish, as well as bullish short-term trend. More technicals details can be found on ZYXI Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙